Armando Araujo, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 12960 Shortline Hwy, Pine Grove, WV 26419 Phone: 304-889-3344 Fax: 304-889-3366 |
News Archive
Intellikine, Inc., a company focused on the discovery and development of innovative, small molecule drugs targeting the PI3K/mTOR pathway, announced today that it has earned $4 million in milestone payments upon the initiation of two Phase 1 clinical trials of IPI-145.
Although the chances of surviving advanced melanoma aren't very good with current therapies, some patients can live for years with cancer that has spread beyond the skin to other organs. Now it may be possible to identify which patients are more likely to survive by analyzing the activity of hundreds of genes involved in the immune response and gene proliferation, according to researchers at NYU Langone Medical Center.
A team of researchers led by Dr Pierre Close, WELBIO researcher at the ULiège GIGA Institute and Dr Francesca Rapino has uncovered a new therapeutic opportunity in the treatment of malignant melanoma that acquired resistance to targeted therapies.
Half of individuals enrolled in consumer-directed plans said they would switch out of the plans if given the opportunity, while about one-third of enrollees in more traditional employer-sponsored health plans said they would change their coverage if they had the chance, according to a survey released on Thursday.
› Verified 2 days ago